Matches in SemOpenAlex for { <https://semopenalex.org/work/W2511830897> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2511830897 endingPage "39" @default.
- W2511830897 startingPage "33" @default.
- W2511830897 abstract "Antithrombin III (Human) (AT III) was administered to 18 patients with documented hereditary AT III deficiency. In eight patients with no ongoing clinical symptoms of thrombosis, the percent increase per unit AT III infused per kilogram of body weight ranged from 1.56% to 2.74%, and the half-life from 43.3 to 77.0 hours. No significant difference was noted between patients receiving and those not receiving coumarin therapy. In clinically ill patients, the in vivo recovery was significantly lower and ranged from 0.64% to 1.90% increase per unit AT III infused/kg. Efficacy of AT III was evaluated in 13 patients for the prevention or treatment of thrombosis. AT III was efficacious as assessed by the absence of thrombotic complications after surgery and/or parturition, and the nonextension and nonrecurrence of thrombosis in patients exhibiting an acute thrombotic episode. No side effects were noted. Follow-up studies indicated no hepatitis B seroconversion and no alanine aminotransferase elevations in patients who were not transfused with other blood products." @default.
- W2511830897 created "2016-09-16" @default.
- W2511830897 creator A5000078467 @default.
- W2511830897 creator A5003895138 @default.
- W2511830897 creator A5008861013 @default.
- W2511830897 creator A5013537551 @default.
- W2511830897 creator A5043235893 @default.
- W2511830897 creator A5044513709 @default.
- W2511830897 creator A5047288397 @default.
- W2511830897 creator A5069527455 @default.
- W2511830897 creator A5070738204 @default.
- W2511830897 creator A5083204200 @default.
- W2511830897 date "1990-01-01" @default.
- W2511830897 modified "2023-10-18" @default.
- W2511830897 title "Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group." @default.
- W2511830897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2403821" @default.
- W2511830897 hasPublicationYear "1990" @default.
- W2511830897 type Work @default.
- W2511830897 sameAs 2511830897 @default.
- W2511830897 citedByCount "21" @default.
- W2511830897 countsByYear W25118308972013 @default.
- W2511830897 countsByYear W25118308972014 @default.
- W2511830897 countsByYear W25118308972015 @default.
- W2511830897 countsByYear W25118308972016 @default.
- W2511830897 countsByYear W25118308972017 @default.
- W2511830897 countsByYear W25118308972018 @default.
- W2511830897 countsByYear W25118308972019 @default.
- W2511830897 countsByYear W25118308972020 @default.
- W2511830897 countsByYear W25118308972023 @default.
- W2511830897 crossrefType "journal-article" @default.
- W2511830897 hasAuthorship W2511830897A5000078467 @default.
- W2511830897 hasAuthorship W2511830897A5003895138 @default.
- W2511830897 hasAuthorship W2511830897A5008861013 @default.
- W2511830897 hasAuthorship W2511830897A5013537551 @default.
- W2511830897 hasAuthorship W2511830897A5043235893 @default.
- W2511830897 hasAuthorship W2511830897A5044513709 @default.
- W2511830897 hasAuthorship W2511830897A5047288397 @default.
- W2511830897 hasAuthorship W2511830897A5069527455 @default.
- W2511830897 hasAuthorship W2511830897A5070738204 @default.
- W2511830897 hasAuthorship W2511830897A5083204200 @default.
- W2511830897 hasConcept C126322002 @default.
- W2511830897 hasConcept C141071460 @default.
- W2511830897 hasConcept C2777557582 @default.
- W2511830897 hasConcept C2778432500 @default.
- W2511830897 hasConcept C2779026020 @default.
- W2511830897 hasConcept C2780868729 @default.
- W2511830897 hasConcept C71924100 @default.
- W2511830897 hasConcept C90924648 @default.
- W2511830897 hasConceptScore W2511830897C126322002 @default.
- W2511830897 hasConceptScore W2511830897C141071460 @default.
- W2511830897 hasConceptScore W2511830897C2777557582 @default.
- W2511830897 hasConceptScore W2511830897C2778432500 @default.
- W2511830897 hasConceptScore W2511830897C2779026020 @default.
- W2511830897 hasConceptScore W2511830897C2780868729 @default.
- W2511830897 hasConceptScore W2511830897C71924100 @default.
- W2511830897 hasConceptScore W2511830897C90924648 @default.
- W2511830897 hasIssue "1" @default.
- W2511830897 hasLocation W25118308971 @default.
- W2511830897 hasOpenAccess W2511830897 @default.
- W2511830897 hasPrimaryLocation W25118308971 @default.
- W2511830897 hasRelatedWork W126979795 @default.
- W2511830897 hasRelatedWork W1499254136 @default.
- W2511830897 hasRelatedWork W15974371 @default.
- W2511830897 hasRelatedWork W168136135 @default.
- W2511830897 hasRelatedWork W1977435299 @default.
- W2511830897 hasRelatedWork W1980190422 @default.
- W2511830897 hasRelatedWork W1999266969 @default.
- W2511830897 hasRelatedWork W2005798908 @default.
- W2511830897 hasRelatedWork W2009932827 @default.
- W2511830897 hasRelatedWork W2020694202 @default.
- W2511830897 hasRelatedWork W2024248545 @default.
- W2511830897 hasRelatedWork W2044464105 @default.
- W2511830897 hasRelatedWork W2051793587 @default.
- W2511830897 hasRelatedWork W2060603007 @default.
- W2511830897 hasRelatedWork W2115509671 @default.
- W2511830897 hasRelatedWork W2128368753 @default.
- W2511830897 hasRelatedWork W2394601116 @default.
- W2511830897 hasRelatedWork W2413432823 @default.
- W2511830897 hasRelatedWork W2418209368 @default.
- W2511830897 hasRelatedWork W2513343933 @default.
- W2511830897 hasVolume "75" @default.
- W2511830897 isParatext "false" @default.
- W2511830897 isRetracted "false" @default.
- W2511830897 magId "2511830897" @default.
- W2511830897 workType "article" @default.